For the better application of BSND and ATP6V1G3 immunohistochemistry in practical pathological diagnosis, whether BSND or ATP6V1G3 positivity is observed in any tumor other than the 12 types of carcinoma examined in the current study is now being investigated in our laboratory. The gene discussed is ATP6V1G3; the disease is carcinoma.